GARD shows great potential for allergy testing in e-liquids

A recently-developed testing method called Genomic Allergen Rapid Detection (GARD) could prove a valuable tool for the e-cig industry, claims a new study sponsored by Imperial Brands’ Fontem Ventures.


Benefits of subscription plans:

  • Stay informed of any legal and market change in the sector that impacts your organization
  • Maximise resources by getting market and legal data analysis daily in one place
  • Make smart decisions by understanding how the regulatory and market landscape evolves
  • Anticipate risks in your decisions by monitoring regulatory changes that impact your organization

Need help?

Contact a sales representative right now and don’t wait

Email us